{"bekendtgoerelseNoegle":{"noticeId":{"value":"506b76a2-792e-4e51-b1d1-a8db299bd634"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00576112-2025"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: Københavns Universitet
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Uddannelse
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: Automated Proteomics System
\n
Beskrivelse: The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio\n of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid\n Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic\n analyses and the precise quantification of low-abundance biomarkers complementary\n to existing proteomic pipelines at PRI.
The ARGO™ HT System is a technologically\n unique platform based on the patented NULISA™ technology, which enables ultra-sensitive\n protein detection at attomolar concentrations—a level of sensitivity unattainable\n with conventional proteomics platforms.
\n
Identifikator for proceduren: 0aaf96c4-fc38-4448-bfff-56e8132c61ad
\n
Tidligere bekendtgørelse: 58583f56-49e6-43c6-975d-8759a7a669a9-01
\n
Intern ID: 043-1633/25-7000
\n
Udbudsprocedure: Udbud med forhandling uden forudgående offentliggørelse
\n
2.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 38433100 Massespektrometer
\n
\n
2.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
\n
2.1.4 Generelle oplysninger
Retsgrundlag:
\n
Direktiv 2014/24/EU
\n
\n
\n
\n
5 Delkontrakt
5.1 Teknisk ID for delkontrakten: LOT-0000
Titel: Automated Proteomics System
\n
Beskrivelse: The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio\n of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid\n Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic\n analyses and the precise quantification of low-abundance biomarkers complementary\n to existing proteomic pipelines at PRI.
The ARGO™ HT System is a technologically\n unique platform based on the patented NULISA™ technology, which enables ultra-sensitive\n protein detection at attomolar concentrations—a level of sensitivity unattainable\n with conventional proteomics platforms.
\n
Intern ID: 043-1633/25-7000
\n
5.1.1 Formål
Kontraktens hovedformål: Varer
\n
Primær klassifikation (cpv): 38433100 Massespektrometer
\n
\n
5.1.2 Udførelsessted
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: 
\n
\n
5.1.6 Generelle oplysninger
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Kvalitet
\n
Navn: kun en leverandør mulig
\n
Beskrivelse: Key technical and scientific differentiators that exclude alternative suppliers:
•\n Patent-protected technology: The NULISA™ platform is protected by multiple patents\n (including US20210278398A1, U.S. Patent No. 12105084, U.S. Patent No. 12188929, and\n EU Patent EP4069731A1), granting ALAMAR Biosciences exclusive rights to manufacture\n and distribute the system and its associated technologies.
• Fully automated high-throughput\n platform: The ARGO™ HT integrates all sample preparation and analysis steps within\n a single instrument, including an embedded qPCR system and support for Next Generation\n Sequencing (NGS). It enables multiplexed analysis of up to 1,000 protein targets across\n 96 to 288 samples per run.
• High sensitivity and specificity: The system leverages\n oligonucleotide-conjugated antibodies and a proprietary dual capture-and-release mechanism,\n which dramatically reduces background noise and delivers highly accurate and reproducible\n results.
• Time efficiency and ease of use: The platform requires less than 30\n minutes of hands-on time, with singleplex results available in under 6 hours, and\n multiplex results in under 15 hours, making it one of the most efficient solutions\n currently available.
\n
Kategori for tildelingskriteriet vægt: Fast værdi (pr. enhed)
Tildelingskriterium talværdi: 1
\n
\n
\n
\n
5.1.15 Teknikker
Rammeaftale:
Ingen rammeaftale
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Oplysninger om klagefrister: I henhold til lov om Klagenævnet for Udbud26 gælder følgende frist for indgivelse\n af klage:
» Klage over ikke at være blevet prækvalificeret skal være indgivet\n til Klagenævnet for Udbud inden 20 kalenderdage fra dagen efter afsendelse af en underretning\n til de berørte ansøgere om, hvem der er blevet udvalgt, jf. udbudslovens § 171, stk.\n 2, eller klagenævnslovens § 2, stk. 1, nr. 1, når underretningen er ledsaget af en\n begrundelse for beslutningen.
I andre situationer skal klage over udbud være\n indgivet til Klagenævnet for Udbud in den:
1. 45 kalenderdage efter, at ordregiveren\n har offentliggjort en bekendtgørelse i Den Europæiske Unions Tidende om, at ordregiveren\n har indgået en kontrakt. Fristen regnes fra dagen efter den dag, hvor bekendtgørelsen\n er blevet offentliggjort.
2. 30 kalenderdage regnet fra dagen efter den dag,\n hvor ordregiveren har underrettet de berørte tilbudsgivere om, at en kontrakt baseret\n på en rammeaftale med genåbning af konkurrencen eller et dynamisk indkøbssystem er\n indgået, hvis underretningen har angivet en begrundelse for beslutningen.
3.\n seks måneder efter, at ordregiveren har indgået en rammeaftale, regnet fra dagen efter\n den dag, hvor ordregiveren har underrettet de berørte ansøgere og tilbudsgivere, jf.\n klagenævns lovens § 2, stk. 2, eller udbudslovens § 171, stk. 4.
4. 20 kalenderdage\n regnet fra dagen efter, at ordregiveren har meddelt sin beslutning, jf. ud budslovens\n § 185, stk. 2.
Senest samtidig med at en klage indgives til Klagenævnet for Udbud,\n skal klageren skriftligt underrette ordregiveren om, at en klage indgives til Klagenævnet\n for Udbud, og om, hvorvidt klagen er indgivet i standstill-perioden, jf. klagenævnslovens\n § 6, stk. 4. I tilfælde, hvor klagen ikke er indgivet i standstill-perioden, skal\n klageren tillige angive, hvorvidt der begæres opsættende virkning af klagen, jf. klagenævnslovens\n § 12, stk. 1.
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
Organisation, der underskriver kontrakten: Københavns Universitet
\n
\n
\n
\n
6 Resultater
Værdien af alle kontrakter tildelt i denne bekendtgørelse: 447.370 Euro
\n
Direkte tildeling:
Begrundelse for direkte tildeling: Kontrakten kan kun tildeles af en bestemt økonomisk aktør på grund af eksklusive rettigheder, herunder intellektuelle ejendomsrettigheder
\n
Anden begrundelse: Key technical and scientific differentiators that exclude alternative suppliers:
•\n Patent-protected technology: The NULISA™ platform is protected by multiple patents\n (including US20210278398A1, U.S. Patent No. 12105084, U.S. Patent No. 12188929, and\n EU Patent EP4069731A1), granting ALAMAR Biosciences exclusive rights to manufacture\n and distribute the system and its associated technologies.
• Fully automated high-throughput\n platform: The ARGO™ HT integrates all sample preparation and analysis steps within\n a single instrument, including an embedded qPCR system and support for Next Generation\n Sequencing (NGS). It enables multiplexed analysis of up to 1,000 protein targets across\n 96 to 288 samples per run.
• High sensitivity and specificity: The system leverages\n oligonucleotide-conjugated antibodies and a proprietary dual capture-and-release mechanism,\n which dramatically reduces background noise and delivers highly accurate and reproducible\n results.
• Time efficiency and ease of use: The platform requires less than 30\n minutes of hands-on time, with singleplex results available in under 6 hours, and\n multiplex results in under 15 hours, making it one of the most efficient solutions\n currently available.
\n
\n
6.1 Resultat delkontrakt-ID: LOT-0000
Der er udvalgt mindst én vinder.
\n
6.1.2 Oplysninger om vinderne
Vinder:
Officielt navn: Alamar Biosciences Europe Srl
\n
Tilbud:
\n
Tilbud – Identifikator: Alamar Quote
\n
ID for delkontrakt eller gruppe af delkontrakter: LOT-0000
\n
Værdien af tilbuddet: 447.370 Euro
\n
Underentreprise: Nej
\n
Kontraktoplysninger:
Identifikator for kontrakten: 043-1633/25-7000
\n
Datoen for udvælgelsen af det vindende tilbud: 06-08-2025
\n
Dato for indgåelse af kontrakten: 01-09-2025
\n
Organisation, der underskriver kontrakten: Københavns Universitet
\n
\n
\n
\n
6.1.4 Statistiske oplysninger
Modtagne tilbud og ansøgninger om deltagelse:
Type modtagne indgivelser: Tilbud
Antal modtagne tilbud og ansøgninger om deltagelse: 1
\n
\n
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: Københavns Universitet
\n
Registreringsnummer: 29979812
\n
Postadresse: Nørregade 10  
\n
By: København K
\n
Postnummer: 1165
\n
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Enhed: Bettina Petersen
\n
E-mail: bettina.dion@adm.ku.dk
\n
Telefon: +45 35327223
\n
Internetadresse: http://www.ku.dk/
\n
Køberprofil: https://eu.eu-supply.com/ctm/company/companyinformation/index/166597
\n
Denne organisations roller:
Køber
\n
Organisation, der underskriver kontrakten
\n
\n
\n
8.1 ORG-0002
Officielt navn: Klagenævnet for Udbud
\n
Registreringsnummer: 37795526
\n
Postadresse: Nævnenes Hus, Toldboden 2  
\n
By: Viborg
\n
Postnummer: 8800
\n
Landsdel (NUTS): Vestjylland (DK041)
\n
Land: Danmark
\n
E-mail: klfu@naevneneshus.dk
\n
Telefon: +45 72405600
\n
Internetadresse: https://naevneneshus.dk/start-din-klage/klagenaevnet-for-udbud/
\n
Denne organisations roller:
Organisation med ansvar for klager
\n
\n
\n
8.1 ORG-0003
Officielt navn: Konkurrence- og Forbrugerstyrelsen
\n
Registreringsnummer: 10294819
\n
Postadresse: Carl Jacobsens vej 35  
\n
By: Valby
\n
Postnummer: 2500
\n
Landsdel (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
E-mail: kfst@kfst.dk
\n
Telefon: +45 41715000
\n
Internetadresse: https://www.kfst.dk
\n
Denne organisations roller:
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
\n
\n
8.1 ORG-0004
Officielt navn: Alamar Biosciences Europe Srl
\n
Den økonomiske operatørs størrelse: Mellemstor virksomhed
\n
Registreringsnummer: 13467230960
\n
Postadresse: Via Amedeo Modigliani, 45  
\n
By: Segrate – Milan
\n
Postnummer: 20054
\n
Landsdel (NUTS): Milano (ITC4C)
\n
Land: Italien
\n
Enhed: Sandra Kyrk
\n
E-mail: skyrk@alamarbio.com
\n
Telefon: +46767607277
\n
Denne organisations roller:
Tilbudsgiver
\n
Vinder af disse delkontrakter: LOT-0000
\n
\n
\n
8.1 ORG-0005
Officielt navn: Mercell Holding ASA
\n
Registreringsnummer: 980921565
\n
Postadresse: Askekroken 11  
\n
By: Oslo
\n
Postnummer: 0277
\n
Landsdel (NUTS): Oslo (NO081)
\n
Land: Norge
\n
Enhed: eSender
\n
E-mail: publication@mercell.com
\n
Telefon: +47 21018800
\n
Fax: +47 21018801
\n
Internetadresse: http://mercell.com/
\n
Denne organisations roller:
TED eSender
\n
\n
\n
\n
Oplysninger om bekendtgørelsen
Bekendtgørelsens ID: 506b76a2-792e-4e51-b1d1-a8db299bd634 - 01
\n
Formulartype: Resultater
\n
Bekendtgørelsestype: Bekendtgørelse om indgåede kontrakter eller koncessionstildeling – standardordningen
\n
Afsendelsesdato for bekendtgørelsen: 03-09-2025 06:33 +00:00
\n
Dato for afsendelse af bekendtgørelsen (eSender): 03-09-2025 06:34 +00:00
\n
Bekendtgørelsens officielle sprog: dansk 
\n
Bekendtgørelsesnummer: 00576112-2025
\n
EUT-S-nummer: 169/2025
\n
Offentliggørelsesdato: 04-09-2025
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: Københavns Universitet
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Education
\n
\n
\n
2 Procedure
2.1 Procedure
Title: Automated Proteomics System
\n
Description: The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio\n of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid\n Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic\n analyses and the precise quantification of low-abundance biomarkers complementary\n to existing proteomic pipelines at PRI.
The ARGO™ HT System is a technologically\n unique platform based on the patented NULISA™ technology, which enables ultra-sensitive\n protein detection at attomolar concentrations—a level of sensitivity unattainable\n with conventional proteomics platforms.
\n
Procedure identifier: 0aaf96c4-fc38-4448-bfff-56e8132c61ad
\n
Previous notice: 58583f56-49e6-43c6-975d-8759a7a669a9-01
\n
Internal identifier: 043-1633/25-7000
\n
Type of procedure: Negotiated without prior call for competition
\n
2.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 38433100 Mass spectrometer
\n
\n
2.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
\n
2.1.4 General information
Legal basis:
\n
Directive 2014/24/EU
\n
\n
\n
\n
5 Lot
5.1 Lot technical ID: LOT-0000
Title: Automated Proteomics System
\n
Description: The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio\n of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid\n Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic\n analyses and the precise quantification of low-abundance biomarkers complementary\n to existing proteomic pipelines at PRI.
The ARGO™ HT System is a technologically\n unique platform based on the patented NULISA™ technology, which enables ultra-sensitive\n protein detection at attomolar concentrations—a level of sensitivity unattainable\n with conventional proteomics platforms.
\n
Internal identifier: 043-1633/25-7000
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 38433100 Mass spectrometer
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: 
\n
\n
5.1.6 General information
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
\n
5.1.10 Award criteria
Criterion:
Type: Quality
\n
Name: kun en leverandør mulig
\n
Description: Key technical and scientific differentiators that exclude alternative suppliers:
•\n Patent-protected technology: The NULISA™ platform is protected by multiple patents\n (including US20210278398A1, U.S. Patent No. 12105084, U.S. Patent No. 12188929, and\n EU Patent EP4069731A1), granting ALAMAR Biosciences exclusive rights to manufacture\n and distribute the system and its associated technologies.
• Fully automated high-throughput\n platform: The ARGO™ HT integrates all sample preparation and analysis steps within\n a single instrument, including an embedded qPCR system and support for Next Generation\n Sequencing (NGS). It enables multiplexed analysis of up to 1,000 protein targets across\n 96 to 288 samples per run.
• High sensitivity and specificity: The system leverages\n oligonucleotide-conjugated antibodies and a proprietary dual capture-and-release mechanism,\n which dramatically reduces background noise and delivers highly accurate and reproducible\n results.
• Time efficiency and ease of use: The platform requires less than 30\n minutes of hands-on time, with singleplex results available in under 6 hours, and\n multiplex results in under 15 hours, making it one of the most efficient solutions\n currently available.
\n
Category of award weight criterion: Fixed value (per unit)
Award criterion number: 1
\n
\n
\n
\n
5.1.15 Techniques
Framework agreement:
No framework agreement
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Information about review deadlines: I henhold til lov om Klagenævnet for Udbud26 gælder følgende frist for indgivelse\n af klage:
» Klage over ikke at være blevet prækvalificeret skal være indgivet\n til Klagenævnet for Udbud inden 20 kalenderdage fra dagen efter afsendelse af en underretning\n til de berørte ansøgere om, hvem der er blevet udvalgt, jf. udbudslovens § 171, stk.\n 2, eller klagenævnslovens § 2, stk. 1, nr. 1, når underretningen er ledsaget af en\n begrundelse for beslutningen.
I andre situationer skal klage over udbud være\n indgivet til Klagenævnet for Udbud in den:
1. 45 kalenderdage efter, at ordregiveren\n har offentliggjort en bekendtgørelse i Den Europæiske Unions Tidende om, at ordregiveren\n har indgået en kontrakt. Fristen regnes fra dagen efter den dag, hvor bekendtgørelsen\n er blevet offentliggjort.
2. 30 kalenderdage regnet fra dagen efter den dag,\n hvor ordregiveren har underrettet de berørte tilbudsgivere om, at en kontrakt baseret\n på en rammeaftale med genåbning af konkurrencen eller et dynamisk indkøbssystem er\n indgået, hvis underretningen har angivet en begrundelse for beslutningen.
3.\n seks måneder efter, at ordregiveren har indgået en rammeaftale, regnet fra dagen efter\n den dag, hvor ordregiveren har underrettet de berørte ansøgere og tilbudsgivere, jf.\n klagenævns lovens § 2, stk. 2, eller udbudslovens § 171, stk. 4.
4. 20 kalenderdage\n regnet fra dagen efter, at ordregiveren har meddelt sin beslutning, jf. ud budslovens\n § 185, stk. 2.
Senest samtidig med at en klage indgives til Klagenævnet for Udbud,\n skal klageren skriftligt underrette ordregiveren om, at en klage indgives til Klagenævnet\n for Udbud, og om, hvorvidt klagen er indgivet i standstill-perioden, jf. klagenævnslovens\n § 6, stk. 4. I tilfælde, hvor klagen ikke er indgivet i standstill-perioden, skal\n klageren tillige angive, hvorvidt der begæres opsættende virkning af klagen, jf. klagenævnslovens\n § 12, stk. 1.
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
Organisation signing the contract: Københavns Universitet
\n
\n
\n
\n
6 Results
Value of all contracts awarded in this notice: 447.370 Euro
\n
Direct award:
Justification for direct award: The contract can be provided only by a particular economic operator because of exclusive rights, including intellectual property rights
\n
Other justification: Key technical and scientific differentiators that exclude alternative suppliers:
•\n Patent-protected technology: The NULISA™ platform is protected by multiple patents\n (including US20210278398A1, U.S. Patent No. 12105084, U.S. Patent No. 12188929, and\n EU Patent EP4069731A1), granting ALAMAR Biosciences exclusive rights to manufacture\n and distribute the system and its associated technologies.
• Fully automated high-throughput\n platform: The ARGO™ HT integrates all sample preparation and analysis steps within\n a single instrument, including an embedded qPCR system and support for Next Generation\n Sequencing (NGS). It enables multiplexed analysis of up to 1,000 protein targets across\n 96 to 288 samples per run.
• High sensitivity and specificity: The system leverages\n oligonucleotide-conjugated antibodies and a proprietary dual capture-and-release mechanism,\n which dramatically reduces background noise and delivers highly accurate and reproducible\n results.
• Time efficiency and ease of use: The platform requires less than 30\n minutes of hands-on time, with singleplex results available in under 6 hours, and\n multiplex results in under 15 hours, making it one of the most efficient solutions\n currently available.
\n
\n
6.1 Result lot ldentifier: LOT-0000
At least one winner was chosen.
\n
6.1.2 Information about winners
Winner:
Official name: Alamar Biosciences Europe Srl
\n
Tender:
\n
Tender identifier: Alamar Quote
\n
Identifier of lot or group of lots: LOT-0000
\n
Value of the tender: 447.370 Euro
\n
Subcontracting: No
\n
Contract information:
Identifier of the contract: 043-1633/25-7000
\n
Date on which the winner was chosen: 06-08-2025
\n
Date of the conclusion of the contract: 01-09-2025
\n
Organisation signing the contract: Københavns Universitet
\n
\n
\n
\n
6.1.4 Statistical information
Received tenders or requests to participate:
Type of received submissions: Tenders
Number of tenders or requests to participate received: 1
\n
\n
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: Københavns Universitet
\n
Registration number: 29979812
\n
Postal address: Nørregade 10  
\n
Town: København K
\n
Postcode: 1165
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Contact point: Bettina Petersen
\n
Email: bettina.dion@adm.ku.dk
\n
Telephone: +45 35327223
\n
Internet address: http://www.ku.dk/
\n
Buyer profile: https://eu.eu-supply.com/ctm/company/companyinformation/index/166597
\n
Roles of this organisation:
Buyer
\n
Organisation signing the contract
\n
\n
\n
8.1 ORG-0002
Official name: Klagenævnet for Udbud
\n
Registration number: 37795526
\n
Postal address: Nævnenes Hus, Toldboden 2  
\n
Town: Viborg
\n
Postcode: 8800
\n
Country subdivision (NUTS): Vestjylland (DK041)
\n
Country: Denmark
\n
Email: klfu@naevneneshus.dk
\n
Telephone: +45 72405600
\n
Internet address: https://naevneneshus.dk/start-din-klage/klagenaevnet-for-udbud/
\n
Roles of this organisation:
Review organisation
\n
\n
\n
8.1 ORG-0003
Official name: Konkurrence- og Forbrugerstyrelsen
\n
Registration number: 10294819
\n
Postal address: Carl Jacobsens vej 35  
\n
Town: Valby
\n
Postcode: 2500
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Email: kfst@kfst.dk
\n
Telephone: +45 41715000
\n
Internet address: https://www.kfst.dk
\n
Roles of this organisation:
Organisation providing more information on the review procedures
\n
\n
\n
8.1 ORG-0004
Official name: Alamar Biosciences Europe Srl
\n
Size of the economic operator: Medium
\n
Registration number: 13467230960
\n
Postal address: Via Amedeo Modigliani, 45  
\n
Town: Segrate – Milan
\n
Postcode: 20054
\n
Country subdivision (NUTS): Milano (ITC4C)
\n
Country: Italy
\n
Contact point: Sandra Kyrk
\n
Email: skyrk@alamarbio.com
\n
Telephone: +46767607277
\n
Roles of this organisation:
Tenderer
\n
Winner of these lots: LOT-0000
\n
\n
\n
8.1 ORG-0005
Official name: Mercell Holding ASA
\n
Registration number: 980921565
\n
Postal address: Askekroken 11  
\n
Town: Oslo
\n
Postcode: 0277
\n
Country subdivision (NUTS): Oslo (NO081)
\n
Country: Norway
\n
Contact point: eSender
\n
Email: publication@mercell.com
\n
Telephone: +47 21018800
\n
Fax: +47 21018801
\n
Internet address: http://mercell.com/
\n
Roles of this organisation:
TED eSender
\n
\n
\n
\n
Notice information
Notice identifier/version: 506b76a2-792e-4e51-b1d1-a8db299bd634 - 01
\n
Form type: Result
\n
Notice type: Contract or concession award notice – standard regime
\n
Notice dispatch date: 03-09-2025 06:33 +00:00
\n
Notice dispatch date (eSender): 03-09-2025 06:34 +00:00
\n
Languages in which this notice is officially available: Danish 
\n
Notice publication number: 00576112-2025
\n
OJ S issue number: 169/2025
\n
Publication date: 04-09-2025
\n
\n \n","opsummeringDA":{"card":{"titel":"Automated Proteomics System","ordregiver":"Københavns Universitet","ordregiverId":"29979812","ordregiverIdDatavasket":"29979812","publiceringsdato":"2025-09-04+02:00","cpvKode":"38433100","cpvTitel":"Massespektrometer","formulartype":"Resultater","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Københavns Universitet"],"beskrivelse":"The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic analyses and the precise quantification of low-abundance biomarkers complementary to existing proteomic pipelines at PRI.\nThe ARGO™ HT System is a technologically unique platform based on the patented NULISA™ technology, which enables ultra-sensitive protein detection at attomolar concentrations—a level of sensitivity unattainable with conventional proteomics platforms.","bkSubTypeKode":"29","bkSubType":"Bekendtgørelse om indgåede kontrakter – det generelle direktiv, standardordningen","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Danmark"],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"Automated Proteomics System","ordregiver":"Københavns Universitet","ordregiverId":"29979812","ordregiverIdDatavasket":"29979812","publiceringsdato":"2025-09-04+02:00","cpvKode":"38433100","cpvTitel":"Mass spectrometer","formulartype":"Result","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Københavns Universitet"],"beskrivelse":"The purpose of the acquisition of the ARGO™ HT System is to expand the service portfolio of the Proteomics Research Infrastructure (PRI) by implementing NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology, which enables highly sensitive proteomic analyses and the precise quantification of low-abundance biomarkers complementary to existing proteomic pipelines at PRI.\nThe ARGO™ HT System is a technologically unique platform based on the patented NULISA™ technology, which enables ultra-sensitive protein detection at attomolar concentrations—a level of sensitivity unattainable with conventional proteomics platforms.","bkSubTypeKode":"29","bkSubType":"Contract award notice – general directive, standard regime","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Denmark"],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]}}